查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1301166

支架技術市場規模、份額和趨勢分析報告：按類型、按疾病類型、按應用、按最終用途、按地區、細分市場趨勢，2023-2030 年

Scaffold Technology Market Size, Share & Trends Analysis Report By Type (Hydrogels, Polymeric Scaffolds), By Disease Type (Cancer, Neurology), By Application, By End-use, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 180 Pages | 商品交期: 2-10個工作天內

價格

腳手架技術市場增長和趨勢

Grand View Research, Inc.最新報告顯示，預計2023年至2030年全球腳手架技術市場規模將以13.87%的複合年增長率增長，2030年達到49.2億美元。

3D細胞培養正在擴大其應用範圍，因為它可以有效地模擬組織的體內生理狀態，從而有效地表達致病的微環境因素。

此外，越來越多的研究集中在新型水凝膠的開發上，例如可注射水凝膠、自愈水凝膠、混合水凝膠和刺激響應水凝膠，預計將在未來幾年創造新的創收機會。

此外，由於近年來再生醫學和組織工程的顯著進展，3D生物打印在器官和組織重建中的應用越來越多。3D生物打印技術是再生醫學領域最有利可圖的進步之一，對市場增長產生積極影響。

許多公司正在開髮用於組織再生的新型 3D 生物打印個性化支架。例如，2022 年 6 月，3D Systems 啟動了與 United Therapeutics Corporation 的研究合作，開發新型 3D 打印器官技術。同樣，納米纖維支架由於其高表面積與體積比以及模仿天然細胞外基質纖維結構的能力而越來越受歡迎。這種支架為細胞附著和增殖提供了有利的微環境，預計將在預測期內促進其採用並推動市場增長。

此外，COVID-19疫情繼續成為腳手架技術市場的積極催化劑。組織工程廣泛用於了解病毒學和流行病學、開發體外模型系統以及尋找對抗傳染病的有效治療解決方案。例如，2021 年10 月發表在《Advanced Healthcare Materials Journal》上的一項研究證明了一種新冠肺炎(COVID-19) 候選疫苗的開發，該候選疫苗採用生物材料支架作為招募免疫細胞的位點，以發展適應性免疫。

腳手架技術市場報告亮點

  • 水凝膠領域已成為最具主導地位的細分市場，2022 年收入佔比最大，為 41.69%。用於製造水凝膠的微加工技術的進步預計將推動該領域的發展。
  • 由於全球每年進行的肌肉骨骼手術數量不斷增加，骨科、肌肉骨骼和脊柱領域在 2022 年佔據了最高的市場份額，達到 52.98%。
  • 北美在腳手架技術行業佔據主導地位，2022 年收入份額最大，為 40.44%。醫療保健支出的增加和對最新腳手架技術的科學認識的提高正在推動該區域市場的發展。
  • 幹細胞治療、再生醫學和組織工程佔據市場主導地位，2022年份額為66.45%。這種增長是由於越來越多地採用支架技術用於美容和重建手術、軟組織腫瘤修復和其他應用。
  • 生物技術和製藥機構細分市場佔據主導地位，2022 年收入份額最大，為 46.51%。該細分市場的增長得益於這些公司在組織工程領域廣泛應用支架技術。

目錄

第一章 調查方法和範圍

  • 市場細分和範圍
  • 市場定義
    • 信息分析
    • 市場塑造和數據可視化
    • 驗證和發布數據
  • 調查假設
  • 信息採購
    • 初步調查
  • 信息或數據分析
  • 市場形成和驗證
  • 市場模式
  • 全球市場：計算複合年增長率
  • 目的

第二章執行摘要

  • 市場快照
  • 段快照
  • 競爭格局的快照

第三章市場變量、趨勢和範圍

  • 市場譜系展望
    • 母公司市場展望
    • 相關/補充市場展望
  • 市場動態
    • 市場驅動力分析
    • 市場約束因素分析
  • 行業分析工具
    • 波特五力分析
    • PESTEL 分析
    • COVID-19 的影響分析

第四章按類型劃分的業務分析

  • 腳手架技術市場：類型變化分析
  • 水凝膠
    • 2018-2030 年水凝膠市場估計和預測（百萬美元）
    • 傷口癒合
    • 3D生物打印
    • 免疫調節
  • 聚合物支架
    • 2018-2030 年聚合物支架市場估計和預測（百萬美元）
  • 微圖案表面微孔板
    • 2018-2030 年微圖案表面微孔板市場估計和預測（百萬美元）
  • 基於納米纖維的支架
    • 2018-2030 年基於納米纖維的腳手架市場估計和預測（百萬美元）

第五章 疾病業務分析

  • 腳手架技術市場：疾病類型的變異分析
  • 骨科、肌肉骨骼系統、脊柱
    • 2018-2030 年骨科、肌肉骨骼和脊柱市場估計與預測（百萬美元）
  • 癌症
    • 2018-2030 年癌症市場估計和預測（百萬美元）
  • 皮膚和表皮
    • 2018-2030 年皮膚和外皮市場估計和預測（百萬美元）
  • 牙科
    • 2018-2030 年牙科市場估計和預測（百萬美元）
  • 心髒病學和血管學
    • 2018-2030 年心髒病學和血管市場估計和預測（百萬美元）
  • 神經病學
    • 2018-2030 年神經病學市場估計和預測（百萬美元）
  • 泌尿科
    • 2018-2030 年泌尿外科市場估計和預測（百萬美元）
  • 消化內科、婦科
    • 2018-2030 年胃腸病學和婦科市場估計和預測（百萬美元）
  • 其他
    • 2018-2030 年其他疾病類型的市場估計和預測（百萬美元）

第六章 按應用分類的業務分析

  • 腳手架技術市場：應用變化分析
  • 幹細胞治療、再生醫學、組織工程
    • 2018-2030年干細胞治療、再生醫學、組織工程市場估計和預測（百萬美元）
  • 藥物發現
    • 2018-2030 年藥物發現市場估計和預測（百萬美元）
  • 其他
    • 2018-2030 年其他應用市場估計和預測（百萬美元）

第七章最終用途業務分析

  • 腳手架技術市場：最終用途變化分析
  • 生物技術和製藥組織
    • 2018-2030 年生物技術和製藥市場估計和預測（百萬美元）
  • 研究和實驗室
    • 2018-2030年研究機構市場預測及預測（百萬美元）
  • 醫院和診斷中心
    • 2018-2030 年醫院和診斷中心市場估計和預測（百萬美元）
  • 其他
    • 2018-2030 年其他最終用途市場估計和預測（百萬美元）

第八章區域業務分析

  • 2022 年和 2030 年腳手架技術市場份額（按地區）
  • 北美
    • 北美腳手架技術市場，2018-2030（百萬美元）
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲腳手架技術市場，2018-2030（百萬美元）
    • 英國
    • 德國
    • 法國
    • 意大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 亞太腳手架技術市場，2018-2030（百萬美元）
    • 日本
    • 中國
    • 印度
    • 澳大利亞
    • 泰國
    • 韓國
  • 拉丁美洲
    • 拉丁美洲腳手架技術市場，2018-2030（百萬美元）
    • 巴西
    • 墨西哥
    • 阿根廷
  • MEA
    • MEA 腳手架技術市場，2018-2030 年（百萬美元）
    • 南非
    • 沙特阿拉伯
    • 阿拉伯聯合酋長國
    • 科威特

第9章 競爭格局

  • 公司分類
  • 戰略規劃
  • 2022 年公司市場份額分析
  • 公司簡介/名單
    • Merck KGaA
    • Thermo Fisher Scientific, Inc.
    • Becton, Dickinson, And Company
    • 3D Biotek LLC
    • Molecular Matrix, Inc.
    • REPROCELL, Inc.
    • Xanofi
    • Tecan Trading AG
    • Matricel Gmbh
    • Pelobiotech
    • Corning Incorporated
    • Akron Biotech
    • 4titude
    • Nuvasive, Inc.
    • Avacta Life Sciences Limited
    • Medtronic
    • Allergan
    • Vericel Corporation
Product Code: GVR-4-68039-913-6

Scaffold Technology Market Growth & Trends

The global scaffold technology market size is expected to reach USD 4.92 billion by 2030, expanding at 13.87% CAGR from 2023 to 2030, according to a new study by Grand View Research, Inc. The application of 3D cell cultures is growing as they are efficient in mimicking the in-vivo physiological state of tissues for efficient representation of disease-causing microenvironmental factors.

Furthermore, increasing research focusing on the development of novel hydrogel types including injectable hydrogels, self-healing hydrogels, hybrid hydrogels, and stimuli-responsive hydrogels are expected to open new revenue generation opportunities in the coming years.

In addition, the significant advancements in regenerative medicine and tissue engineering in recent years have increased the adoption of 3D bioprinting for organ and tissue reconstruction procedures. The 3D bioprinting technique is one of the most lucrative advancements in the field of regenerative medicine which can positively affect market growth.

Numerous companies are developing new 3D bio-printed personalized scaffolds for tissue regeneration. For instance, in June 2022, 3D Systems entered a collaboration with United Therapeutics Corporation for the development of novel 3D-printed organ technologies. Similarly, nanofiber scaffolds are gaining traction due to their high surface area-to-volume ratio and their ability to mimic the fibrous structure of the natural extracellular matrix. Such scaffolds provide a suitable microenvironment for cell adhesion and proliferation, which is anticipated to boost their adoption and drive market growth during the forecast period.

Moreover, the COVID-19 pandemic remains a positive catalyst for the market for scaffold technology. Tissue engineering is extensively used for understanding virology and epidemiology, developing in-vitro model systems, and finding efficient therapeutic solutions for dealing with infection. For instance, a study published in the Advanced Healthcare Materials Journal in October 2021 demonstrated the development of a COVID-19 vaccine candidate that employs biomaterial scaffolds as recruitment sites for immune cells for the development of adaptive immunity.

Scaffold Technology Market Report Highlights

  • The hydrogels segment emerged as the most dominant segment and accounted for the largest revenue share of 41.69% in 2022. Technological advancements in the microfabrication techniques used for the creation of hydrogels are expected to fuel the segment growth
  • The orthopedics, musculoskeletal, and spine segment held the highest market share of 52.98% in 2022 due to the increasing number of musculoskeletal procedures performed annually worldwide
  • North America dominated the scaffold technology industry and accounted for the largest revenue share of 40.44% in 2022. Rising healthcare expenditure and increasing scientific awareness about the latest scaffold technologies are driving the regional market
  • The stem cell therapy, regenerative medicine, and tissue engineering segment dominated the market with a share of 66.45% in 2022. The growth is attributed to the growing adoption of scaffold technology for aesthetic and reconstruction surgeries, soft tissue tumor repair, and other applications
  • The biotechnology and pharmaceutical organizations segment dominated the market with the largest revenue share of 46.51% in 2022. The growth in the segment is due to the extensive application of scaffold technology by these organizations in tissue engineering fields

Table of Contents

Chapter 1. Methodology And Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Information Analysis
    • 1.2.2. Market Formulation & Data Visualization
    • 1.2.3. Data Validation & Publishing
  • 1.3. Research Assumptions
  • 1.4. Information Procurement
    • 1.4.1. Primary Research
  • 1.5. Information Or Data Analysis
  • 1.6. Market Formulation & Validation
  • 1.7. Market Model
  • 1.8. Global Market: CAGR Calculation
  • 1.9. Objectives
    • 1.9.1. Objective 1:
    • 1.9.2. Objective 2:

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing Demand For 3D Cellular Models In Translational Research
      • 3.2.1.2. Increasing Demand For Body Reconstruction Procedures And Tissue Engineering
      • 3.2.1.3. Advancements In Scaffold Technologies
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Introduction Of Scaffold-Free Technology For 3D Cell Culture
      • 3.2.2.2. Lack Of Consistency In Generated Results
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Type Business Analysis

  • 4.1. Scaffold Technology Market: Type Movement Analysis
  • 4.2. Hydrogels
    • 4.2.1. Hydrogels Market Estimates And Forecast 2018 To 2030 (USD Million)
    • 4.2.2. Wound Healing
      • 4.2.2.1. Wound Healing Market Estimates And Forecast 2018 To 2030 (USD Million)
    • 4.2.3. 3D Bioprinting
      • 4.2.3.1. 3D Bioprinting Market Estimates And Forecast 2018 To 2030 (USD Million)
    • 4.2.4. Immunomodulation
      • 4.2.4.1. Immunomodulation Market Estimates And Forecast 2018 To 2030 (USD Million)
  • 4.3. Polymeric Scaffolds
    • 4.3.1. Polymeric Scaffolds Market Estimates And Forecast 2018 To 2030 (USD Million)
  • 4.4. Micropatterned Surface Microplates
    • 4.4.1. Micropatterned Surface Microplates Market Estimates And Forecast 2018 To 2030 (USD Million)
  • 4.5. Nanofiber Based Scaffolds
    • 4.5.1. Nanofiber-Based Scaffolds Market Estimates And Forecast 2018 To 2030 (USD Million)

Chapter 5. Disease Type Business Analysis

  • 5.1. Scaffold Technology Market: Disease Type Movement Analysis
  • 5.2. Orthopedics, Musculoskeletal, & Spine
    • 5.2.1. Orthopedics, Musculoskeletal, & Spine Market Estimates And Forecast 2018 To 2030 (USD Million)
  • 5.3. Cancer
    • 5.3.1. Cancer Market Estimates And Forecast 2018 To 2030 (USD Million)
  • 5.4. Skin & Integumentary
    • 5.4.1. Skin & Integumentary Market Estimates And Forecast 2018 To 2030 (USD Million)
  • 5.5. Dental
    • 5.5.1. Dental Market Estimates And Forecast 2018 To 2030 (USD Million)
  • 5.6. Cardiology & Vascular
    • 5.6.1. Cardiology & Vascular Market Estimates And Forecast 2018 To 2030 (USD Million)
  • 5.7. Neurology
    • 5.7.1. Neurology Market Estimates And Forecast 2018 To 2030 (USD Million)
  • 5.8. Urology
    • 5.8.1. Urology Market Estimates And Forecast 2018 To 2030 (USD Million)
  • 5.9. GI, Gynecology
    • 5.9.1. GI, Gynecology Market Estimates And Forecast 2018 To 2030 (USD Million)
  • 5.10. Others
    • 5.10.1. Other Disease Type Market Estimates And Forecast 2018 To 2030 (USD Million)

Chapter 6. Application Business Analysis

  • 6.1. Scaffold Technology Market: Application Movement Analysis
  • 6.2. Stem Cell Therapy, Regenerative Medicine, & Tissue Engineering
    • 6.2.1. Stem Cell Therapy, Regenerative Medicine, & Tissue Engineering Market Estimates And Forecast 2018 To 2030 (USD Million)
  • 6.3. Drug Discovery
    • 6.3.1. Drug Discovery Market Estimates And Forecast 2018 To 2030 (USD Million)
  • 6.4. Others
    • 6.4.1. Other Applications Market Estimates And Forecast 2018 To 2030 (USD Million)

Chapter 7. End-Use Business Analysis

  • 7.1. Scaffold Technology Market: End-Use Movement Analysis
  • 7.2. Biotechnology And Pharmaceutical Organizations
    • 7.2.1. Biotechnology And Pharmaceutical Organizations Market Estimates And Forecast 2018 To 2030 (USD Million)
  • 7.3. Research Laboratories And Institutes
    • 7.3.1. Research Laboratories And Institutes Market Estimates And Forecast 2018 To 2030 (USD Million)
  • 7.4. Hospitals And Diagnostic Centers
    • 7.4.1. Hospitals And Diagnostic Centers Market Estimates And Forecast 2018 To 2030 (USD Million)
  • 7.5. Others
    • 7.5.1. Other End-Uses Market Estimates And Forecast 2018 To 2030 (USD Million)

Chapter 8. Regional Business Analysis

  • 8.1. Scaffold Technology Market Share By Region, 2022 & 2030
  • 8.2. North America
    • 8.2.1. North America Scaffold Technology Market, 2018 - 2030 (USD Million)
    • 8.2.2. U.S.
      • 8.2.2.1. Key Country Dynamics
      • 8.2.2.2. Target Disease Prevalence
      • 8.2.2.3. Competitive Scenario
      • 8.2.2.4. Regulatory Framework
      • 8.2.2.5. U.S. Scaffold Technology Market, 2018 - 2030 (USD Million)
    • 8.2.3. Canada
      • 8.2.3.1. Key Country Dynamics
      • 8.2.3.2. Target Disease Prevalence
      • 8.2.3.3. Competitive Scenario
      • 8.2.3.4. Regulatory Framework
      • 8.2.3.5. Canada Scaffold Technology Market, 2018 - 2030 (USD Million)
  • 8.3. Europe
    • 8.3.1. Europe Scaffold Technology Market, 2018 - 2030 (USD Million)
    • 8.3.2. UK
      • 8.3.2.1. Key Country Dynamics
      • 8.3.2.2. Target Disease Prevalence
      • 8.3.2.3. Competitive Scenario
      • 8.3.2.4. Regulatory Framework
      • 8.3.2.5. UK Scaffold Technology Market, 2018 - 2030 (USD Million)
    • 8.3.3. Germany
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Target Disease Prevalence
      • 8.3.3.3. Competitive Scenario
      • 8.3.3.4. Regulatory Framework
      • 8.3.3.5. Germany Scaffold Technology Market, 2018 - 2030 (USD Million)
    • 8.3.4. France
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Target Disease Prevalence
      • 8.3.4.3. Competitive Scenario
      • 8.3.4.4. Regulatory Framework
      • 8.3.4.5. France Scaffold Technology Market, 2018 - 2030 (USD Million)
    • 8.3.5. Italy
      • 8.3.5.1. Key Country Dynamics
      • 8.3.5.2. Target Disease Prevalence
      • 8.3.5.3. Competitive Scenario
      • 8.3.5.4. Regulatory Framework
      • 8.3.5.5. Italy Scaffold Technology Market, 2018 - 2030 (USD Million)
    • 8.3.6. Spain
      • 8.3.6.1. Key Country Dynamics
      • 8.3.6.2. Target Disease Prevalence
      • 8.3.6.3. Competitive Scenario
      • 8.3.6.4. Regulatory Framework
      • 8.3.6.5. Spain Scaffold Technology Market, 2018 - 2030 (USD Million)
    • 8.3.7. Denmark
      • 8.3.7.1. Key Country Dynamics
      • 8.3.7.2. Target Disease Prevalence
      • 8.3.7.3. Competitive Scenario
      • 8.3.7.4. Regulatory Framework
      • 8.3.7.5. Denmark Scaffold Technology Market, 2018 - 2030 (USD Million)
    • 8.3.8. Sweden
      • 8.3.8.1. Key Country Dynamics
      • 8.3.8.2. Target Disease Prevalence
      • 8.3.8.3. Competitive Scenario
      • 8.3.8.4. Regulatory Framework
      • 8.3.8.5. Sweden Scaffold Technology Market, 2018 - 2030 (USD Million)
    • 8.3.9. Norway
      • 8.3.9.1. Key Country Dynamics
      • 8.3.9.2. Target Disease Prevalence
      • 8.3.9.3. Competitive Scenario
      • 8.3.9.4. Regulatory Framework
      • 8.3.9.5. Norway Scaffold Technology Market, 2018 - 2030 (USD Million)
  • 8.4. Asia Pacific
    • 8.4.1. Asia Pacific Scaffold Technology Market, 2018 - 2030 (USD Million)
    • 8.4.2. Japan
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Target Disease Prevalence
      • 8.4.2.3. Competitive Scenario
      • 8.4.2.4. Regulatory Framework
      • 8.4.2.5. Japan Scaffold Technology Market, 2018 - 2030 (USD Million)
    • 8.4.3. China
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Target Disease Prevalence
      • 8.4.3.3. Competitive Scenario
      • 8.4.3.4. Regulatory Framework
      • 8.4.3.5. China Scaffold Technology Market, 2018 - 2030 (USD Million)
    • 8.4.4. India
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Target Disease Prevalence
      • 8.4.4.3. Competitive Scenario
      • 8.4.4.4. Regulatory Framework
      • 8.4.4.5. India Scaffold Technology Market, 2018 - 2030 (USD Million)
    • 8.4.5. Australia
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Target Disease Prevalence
      • 8.4.5.3. Competitive Scenario
      • 8.4.5.4. Regulatory Framework
      • 8.4.5.5. Australia Scaffold Technology Market, 2018 - 2030 (USD Million)
    • 8.4.6. Thailand
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Target Disease Prevalence
      • 8.4.6.3. Competitive Scenario
      • 8.4.6.4. Regulatory Framework
      • 8.4.6.5. Thailand Scaffold Technology Market, 2018 - 2030 (USD Million)
    • 8.4.7. South Korea
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Target Disease Prevalence
      • 8.4.7.3. Competitive Scenario
      • 8.4.7.4. Regulatory Framework
      • 8.4.7.5. South Korea Scaffold Technology Market, 2018 - 2030 (USD Million)
  • 8.5. Latin America
    • 8.5.1. Latin America Scaffold Technology Market, 2018 - 2030 (USD Million)
    • 8.5.2. Brazil
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Target Disease Prevalence
      • 8.5.2.3. Competitive Scenario
      • 8.5.2.4. Regulatory Framework
      • 8.5.2.5. Brazil Scaffold Technology Market, 2018 - 2030 (USD Million)
    • 8.5.3. Mexico
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Target Disease Prevalence
      • 8.5.3.3. Competitive Scenario
      • 8.5.3.4. Regulatory Framework
      • 8.5.3.5. Mexico Scaffold Technology Market, 2018 - 2030 (USD Million)
    • 8.5.4. Argentina
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Target Disease Prevalence
      • 8.5.4.3. Competitive Scenario
      • 8.5.4.4. Regulatory Framework
      • 8.5.4.5. Argentina Scaffold Technology Market, 2018 - 2030 (USD Million)
  • 8.6. MEA
    • 8.6.1. MEA Scaffold Technology Market, 2018 - 2030 (USD Million)
    • 8.6.2. South Africa
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Target Disease Prevalence
      • 8.6.2.3. Competitive Scenario
      • 8.6.2.4. Regulatory Framework
      • 8.6.2.5. South Africa Scaffold Technology Market, 2018 - 2030 (USD Million)
    • 8.6.3. Saudi Arabia
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Target Disease Prevalence
      • 8.6.3.3. Competitive Scenario
      • 8.6.3.4. Regulatory Framework
      • 8.6.3.5. Saudi Arabia Scaffold Technology Market, 2018 - 2030 (USD Million)
    • 8.6.4. UAE
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Target Disease Prevalence
      • 8.6.4.3. Competitive Scenario
      • 8.6.4.4. Regulatory Framework
      • 8.6.4.5. UAE Scaffold Technology Market, 2018 - 2030 (USD Million)
    • 8.6.5. Kuwait
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Target Disease Prevalence
      • 8.6.5.3. Competitive Scenario
      • 8.6.5.4. Regulatory Framework
      • 8.6.5.5. Kuwait Scaffold Technology Market, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company Categorization
  • 9.2. Strategy Mapping
  • 9.3. Company Market Share Analysis, 2022
  • 9.4. Company Profiles/Listing
    • 9.4.1. Merck KGaA
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.1.3. Product Benchmarking
      • 9.4.1.4. Strategic Initiatives
    • 9.4.2. Thermo Fisher Scientific, Inc.
      • 9.4.2.1. Company Overview
      • 9.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.2.3. Product Benchmarking
      • 9.4.2.4. Strategic Initiatives
    • 9.4.3. Becton, Dickinson, And Company
      • 9.4.3.1. Company Overview
      • 9.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.3.3. Product Benchmarking
      • 9.4.3.4. Strategic Initiatives
    • 9.4.4. 3D Biotek LLC
      • 9.4.4.1. Company Overview
      • 9.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.4.3. Product Benchmarking
      • 9.4.4.4. Strategic Initiatives
    • 9.4.5. Molecular Matrix, Inc.
      • 9.4.5.1. Company Overview
      • 9.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.5.3. Product Benchmarking
      • 9.4.5.4. Strategic Initiatives
    • 9.4.6. REPROCELL, Inc.
      • 9.4.6.1. Company Overview
      • 9.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.6.3. Product Benchmarking
      • 9.4.6.4. Strategic Initiatives
    • 9.4.7. Xanofi
      • 9.4.7.1. Company Overview
      • 9.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.7.3. Product Benchmarking
      • 9.4.7.4. Strategic Initiatives
    • 9.4.8. Tecan Trading AG
      • 9.4.8.1. Company Overview
      • 9.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.8.3. Product Benchmarking
      • 9.4.8.4. Strategic Initiatives
    • 9.4.9. Matricel Gmbh
      • 9.4.9.1. Company Overview
      • 9.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.9.3. Product Benchmarking
      • 9.4.9.4. Strategic Initiatives
    • 9.4.10. Pelobiotech
      • 9.4.10.1. Company Overview
      • 9.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.10.3. Product Benchmarking
      • 9.4.10.4. Strategic Initiatives
    • 9.4.11. Corning Incorporated
      • 9.4.11.1. Company Overview
      • 9.4.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.11.3. Product Benchmarking
      • 9.4.11.4. Strategic Initiatives
    • 9.4.12. Akron Biotech
      • 9.4.12.1. Company Overview
      • 9.4.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.12.3. Product Benchmarking
      • 9.4.12.4. Strategic Initiatives
    • 9.4.13. 4titude
      • 9.4.13.1. Company Overview
      • 9.4.13.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.13.3. Product Benchmarking
      • 9.4.13.4. Strategic Initiatives
    • 9.4.14. Nuvasive, Inc.
      • 9.4.14.1. Company Overview
      • 9.4.14.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.14.3. Product Benchmarking
      • 9.4.14.4. Strategic Initiatives
    • 9.4.15. Avacta Life Sciences Limited
      • 9.4.15.1. Company Overview
      • 9.4.15.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.15.3. Product Benchmarking
      • 9.4.15.4. Strategic Initiatives
    • 9.4.16. Medtronic
      • 9.4.16.1. Company Overview
      • 9.4.16.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.16.3. Product Benchmarking
      • 9.4.16.4. Strategic Initiatives
    • 9.4.17. Allergan
      • 9.4.17.1. Company Overview
      • 9.4.17.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.17.3. Product Benchmarking
      • 9.4.17.4. Strategic Initiatives
    • 9.4.18. Vericel Corporation
      • 9.4.18.1. Company Overview
      • 9.4.18.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.18.3. Product Benchmarking
      • 9.4.18.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 Global scaffold technology market, by type, 2018 - 2030 (USD Million)
  • Table 3 Global scaffold technology market, by disease type, 2018 - 2030 (USD Million)
  • Table 4 Global scaffold technology market, by application, 2018 - 2030 (USD Million)
  • Table 5 Global scaffold technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 6 Global scaffold technology market, by region, 2018 - 2030 (USD Million)
  • Table 7 North America scaffold technology market, by type, 2018 - 2030 (USD Million)
  • Table 8 North America scaffold technology market, by disease type, 2018 - 2030 (USD Million)
  • Table 9 North America scaffold technology market, by application, 2018 - 2030 (USD Million)
  • Table 10 North America scaffold technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 11 North America scaffold technology market, by country, 2018 - 2030 (USD Million)
  • Table 12 U.S. scaffold technology market, by type, 2018 - 2030 (USD Million)
  • Table 13 U.S. scaffold technology market, by disease type, 2018 - 2030 (USD Million)
  • Table 14 U.S. scaffold technology market, by application, 2018 - 2030 (USD Million)
  • Table 15 U.S. scaffold technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 16 Canada scaffold technology market, by type, 2018 - 2030 (USD Million)
  • Table 17 Canada scaffold technology market, by disease type, 2018 - 2030 (USD Million)
  • Table 18 Canada scaffold technology market, by application, 2018 - 2030 (USD Million)
  • Table 19 Canada scaffold technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 20 Europe scaffold technology market, by type, 2018 - 2030 (USD Million)
  • Table 21 Europe scaffold technology market, by disease type, 2018 - 2030 (USD Million)
  • Table 22 Europe scaffold technology market, by application, 2018 - 2030 (USD Million)
  • Table 23 Europe scaffold technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 24 Europe scaffold technology market, by country, 2018 - 2030 (USD Million)
  • Table 25 Germany scaffold technology market, by type, 2018 - 2030 (USD Million)
  • Table 26 Germany scaffold technology market, by disease type, 2018 - 2030 (USD Million)
  • Table 27 Germany scaffold technology market, by application, 2018 - 2030 (USD Million)
  • Table 28 Germany scaffold technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 29 UK scaffold technology market, by type, 2018 - 2030 (USD Million)
  • Table 30 UK scaffold technology market, by disease type, 2018 - 2030 (USD Million)
  • Table 31 UK scaffold technology market, by application, 2018 - 2030 (USD Million)
  • Table 32 UK scaffold technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 33 France scaffold technology market, by type, 2018 - 2030 (USD Million)
  • Table 34 France scaffold technology market, by disease type, 2018 - 2030 (USD Million)
  • Table 35 France scaffold technology market, by application, 2018 - 2030 (USD Million)
  • Table 36 France scaffold technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 37 Italy scaffold technology market, by type, 2018 - 2030 (USD Million)
  • Table 38 Italy scaffold technology market, by disease type, 2018 - 2030 (USD Million)
  • Table 39 Italy scaffold technology market, by application, 2018 - 2030 (USD Million)
  • Table 40 Italy scaffold technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 41 Spain scaffold technology market, by type, 2018 - 2030 (USD Million)
  • Table 42 Spain scaffold technology market, by disease type, 2018 - 2030 (USD Million)
  • Table 43 Spain scaffold technology market, by application, 2018 - 2030 (USD Million)
  • Table 44 Spain scaffold technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 45 Denmark scaffold technology market, by type, 2018 - 2030 (USD Million)
  • Table 46 Denmark scaffold technology market, by disease type, 2018 - 2030 (USD Million)
  • Table 47 Denmark scaffold technology market, by application, 2018 - 2030 (USD Million)
  • Table 48 Denmark scaffold technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 49 Sweden scaffold technology market, by type, 2018 - 2030 (USD Million)
  • Table 50 Sweden scaffold technology market, by disease type, 2018 - 2030 (USD Million)
  • Table 51 Sweden scaffold technology market, by application, 2018 - 2030 (USD Million)
  • Table 52 Sweden scaffold technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 53 Norway scaffold technology market, by type, 2018 - 2030 (USD Million)
  • Table 54 Norway scaffold technology market, by disease type, 2018 - 2030 (USD Million)
  • Table 55 Norway scaffold technology market, by application, 2018 - 2030 (USD Million)
  • Table 56 Norway scaffold technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 57 Asia Pacific scaffold technology market, by type, 2018 - 2030 (USD Million)
  • Table 58 Asia Pacific scaffold technology market, by disease type, 2018 - 2030 (USD Million)
  • Table 59 Asia Pacific scaffold technology market, by application, 2018 - 2030 (USD Million)
  • Table 60 Asia Pacific scaffold technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 61 Asia Pacific scaffold technology market, by country, 2018 - 2030 (USD Million)
  • Table 62 Japan scaffold technology market, by type, 2018 - 2030 (USD Million)
  • Table 63 Japan scaffold technology market, by disease type, 2018 - 2030 (USD Million)
  • Table 64 Japan scaffold technology market, by application, 2018 - 2030 (USD Million)
  • Table 65 Japan scaffold technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 66 China scaffold technology market, by type, 2018 - 2030 (USD Million)
  • Table 67 China scaffold technology market, by disease type, 2018 - 2030 (USD Million)
  • Table 68 China scaffold technology market, by application, 2018 - 2030 (USD Million)
  • Table 69 China scaffold technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 70 India scaffold technology market, by type, 2018 - 2030 (USD Million)
  • Table 71 India scaffold technology market, by disease type, 2018 - 2030 (USD Million)
  • Table 72 India scaffold technology market, by application, 2018 - 2030 (USD Million)
  • Table 73 India scaffold technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 74 Australia scaffold technology market, by type, 2018 - 2030 (USD Million)
  • Table 75 Australia scaffold technology market, by disease type, 2018 - 2030 (USD Million)
  • Table 76 Australia scaffold technology market, by application, 2018 - 2030 (USD Million)
  • Table 77 Australia scaffold technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 78 Thailand scaffold technology market, by type, 2018 - 2030 (USD Million)
  • Table 79 Thailand scaffold technology market, by disease type, 2018 - 2030 (USD Million)
  • Table 80 Thailand scaffold technology market, by application, 2018 - 2030 (USD Million)
  • Table 81 Thailand scaffold technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 82 South Korea scaffold technology market, by type, 2018 - 2030 (USD Million)
  • Table 83 South Korea scaffold technology market, by disease type, 2018 - 2030 (USD Million)
  • Table 84 South Korea scaffold technology market, by application, 2018 - 2030 (USD Million)
  • Table 85 South Korea scaffold technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 86 Latin America scaffold technology market, by type, 2018 - 2030 (USD Million)
  • Table 87 Latin America scaffold technology market, by disease type, 2018 - 2030 (USD Million)
  • Table 88 Latin America scaffold technology market, by application, 2018 - 2030 (USD Million)
  • Table 89 Latin America scaffold technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 90 Latin America scaffold technology market, by country, 2018 - 2030 (USD Million)
  • Table 91 Brazil scaffold technology market, by type, 2018 - 2030 (USD Million)
  • Table 92 Brazil scaffold technology market, by disease type, 2018 - 2030 (USD Million)
  • Table 93 Brazil scaffold technology market, by application, 2018 - 2030 (USD Million)
  • Table 94 Brazil scaffold technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 95 Mexico scaffold technology market, by type, 2018 - 2030 (USD Million)
  • Table 96 Mexico scaffold technology market, by disease type, 2018 - 2030 (USD Million)
  • Table 97 Mexico scaffold technology market, by application, 2018 - 2030 (USD Million)
  • Table 98 Mexico scaffold technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 99 Argentina scaffold technology market, by type, 2018 - 2030 (USD Million)
  • Table 100 Argentina scaffold technology market, by disease type, 2018 - 2030 (USD Million)
  • Table 101 Argentina scaffold technology market, by application, 2018 - 2030 (USD Million)
  • Table 102 Argentina scaffold technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 103 Middle East and Africa scaffold technology market, by type, 2018 - 2030 (USD Million)
  • Table 104 Middle East and Africa scaffold technology market, by disease type, 2018 - 2030 (USD Million)
  • Table 105 Middle East and Africa scaffold technology market, by application, 2018 - 2030 (USD Million)
  • Table 106 Middle East and Africa scaffold technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 107 Middle East and Africa scaffold technology market, by region, 2018 - 2030 (USD Million)
  • Table 108 South Africa scaffold technology market, by type, 2018 - 2030 (USD Million)
  • Table 109 South Africa scaffold technology market, by disease type, 2018 - 2030 (USD Million)
  • Table 110 South Africa scaffold technology market, by application, 2018 - 2030 (USD Million)
  • Table 111 South Africa scaffold technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 112 Saudi Arabia scaffold technology market, by type, 2018 - 2030 (USD Million)
  • Table 113 Saudi Arabia scaffold technology market, by disease type, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia scaffold technology market, by application, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia scaffold technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 116 UAE scaffold technology market, by type, 2018 - 2030 (USD Million)
  • Table 117 UAE scaffold technology market, by disease type, 2018 - 2030 (USD Million)
  • Table 118 UAE scaffold technology market, by application, 2018 - 2030 (USD Million)
  • Table 119 UAE scaffold technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 120 Kuwait scaffold technology market, by type, 2018 - 2030 (USD Million)
  • Table 121 Kuwait scaffold technology market, by disease type, 2018 - 2030 (USD Million)
  • Table 122 Kuwait scaffold technology market, by application, 2018 - 2030 (USD Million)
  • Table 123 Kuwait scaffold technology market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Scaffold technology market segmentation
  • Fig. 8 Market snapshot, 2022
  • Fig. 9 Market trends & outlook
  • Fig. 10 Market driver relevance analysis (current & future impact)
  • Fig. 11 Market restraint relevance analysis (current & future impact)
  • Fig. 12 PESTEL analysis
  • Fig. 13 Porter's five forces analysis
  • Fig. 14 Scaffold technology market: Type outlook and key takeaways
  • Fig. 15 Scaffold technology market: Type movement analysis
  • Fig. 16 Hydrogels market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 17 Wound healing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 18 3D bioprinting market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Immunomodulation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Polymeric scaffolds market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Micropatterned surface microplates market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Nanofiber based scaffolds market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Scaffold technology market: Disease type outlook and key takeaways
  • Fig. 24 Scaffold technology market: Disease type movement analysis
  • Fig. 25 Orthopedics, musculoskeletal, & spine market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Cancer market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Skin & integumentary market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Dental market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Cardiology & vascular market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Neurology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Urology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 GI, gynecology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Other disease types market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Scaffold technology market: Application outlook and key takeaways
  • Fig. 35 Scaffold technology market: Application movement analysis
  • Fig. 36 Stem cell therapy, regenerative medicine, & tissue engineering market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Drug discovery market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Other applications market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Scaffold technology market: End-Use outlook and key takeaways
  • Fig. 40 Scaffold technology market: End-Use movement analysis
  • Fig. 41 Biotechnology and pharmaceutical organizations market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Research laboratories and institutes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Hospitals and diagnostic center market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Other end-uses market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 Global scaffold technology market: Regional outlook and key takeaways
  • Fig. 46 Global scaffold technology market: Regional movement analysis
  • Fig. 47 North America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 Europe market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Germany market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 UK market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 France market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Italy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 Spain market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Denmark market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 57 Sweden market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 58 Norway market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 59 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 60 Japan market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 61 China market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 India market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 63 Australia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 64 Thailand market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 65 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 66 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 67 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 68 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 69 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 70 MEA market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 71 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 72 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 73 UAE market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 74 Kuwait market estimates and forecast, 2018 - 2030 (USD Million)